Bruce M Halpryn
Vorstandsvorsitzender bei Eikonoklastes Therapeutics, Inc.
Aktive Positionen von Bruce M Halpryn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Eikonoklastes Therapeutics, Inc.
 Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Vorstandsvorsitzender | 01.03.2019 | - |
| Vorsitzender | 01.03.2019 | - | |
| Gründer | 01.03.2019 | - |
Karriereverlauf von Bruce M Halpryn
Ehemalige bekannte Positionen von Bruce M Halpryn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Direktor/Vorstandsmitglied | 01.02.2017 | 01.04.2024 |
| Geschäftsführer | 01.02.2017 | 01.04.2024 | |
| Gründer | 01.02.2017 | 01.04.2024 | |
| Unternehmenssekretär | 01.02.2017 | 01.04.2024 |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Health Technology |
- Börse
- Insiders
- Bruce M Halpryn
- Erfahrung
